The synapse in schizophrenia

European Journal of Neuroscience

Volumn 39, Issue 7, 2014, Pages 1059-1067

  Pocklington, Andrew J ^a   O'Donovan, Michael ^a   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Proteomics; Psychiatric genetics; Synaptic plasticity

Indexed keywords

ARTICLE; GENETIC ASSOCIATION; GLUTAMATERGIC SIGNALLING PATHWAY; HUMAN; MACROMOLECULE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE; ANIMAL; COPY NUMBER VARIATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; DNA COPY NUMBER VARIATIONS; HUMANS; SCHIZOPHRENIA; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84898755080     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12489     Document Type: Article

References (101)

1. Abi-Dargham, A. (2007) Alterations of serotonin transmission in schizophrenia. Int. Rev. Neurobiol., 78, 133-164.
2. Bayes, A., van de Lagemaat, L.N., Collins, M.O., Croning, M.D., Whittle, I.R., Choudhary, J.S. & Grant, S.G. (2011) Characterization of the proteome, diseases and evolution of the human postsynaptic density. Nat. Neurosci., 14, 19-21.
3. Becamel, C., Alonso, G., Galeotti, N., Demey, E., Jouin, P., Ullmer, C., Dumuis, A., Bockaert, J. & Marin, P. (2002) Synaptic multiprotein complexes associated with 5-HT(2C) receptors: a proteomic approach. EMBO J., 21, 2332-2342.
4. Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C. & Snyder, M. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature, 489, 57-74.
5. Blake, D.J., Forrest, M., Chapman, R.M., Tinsley, C.L., O'Donovan, M.C. & Owen, M.J. (2010) TCF4, schizophrenia, and Pitt-Hopkins Syndrome. Schizophrenia Bull., 36, 443-447.
6. Boksa, P. (2010) Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun., 24, 881-897.
7. Bramham, C.R., Alme, M.N., Bittins, M., Kuipers, S.D., Nair, R.R., Pai, B., Panja, D., Schubert, M., Soule, J., Tiron, A. & Wibrand, K. (2010) The Arc of synaptic memory. Exp. Brain Res., 200, 125-140.
8. Brene, S., Messer, C. & Nestler, E.J. (1998) Expression of messenger RNAs encoding ionotropic glutamate receptors in rat brain: regulation by haloperidol. Neuroscience, 84, 813-823.
9. Brown, A.S. & Derkits, E.J. (2010) Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiat., 167, 261-280.
10. Bundy, H., Stahl, D. & MacCabe, J.H. (2011) A systematic review and meta-analysis of the fertility of patients with schizophrenia and their unaffected relatives. Acta Psychiat. Scand., 123, 98-106.
11. Cardno, A.G. & Gottesman, I.I. (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet., 97, 12-17.
12. Chaignat, E., Yahya-Graison, E.A., Henrichsen, C.N., Chrast, J., Schutz, F., Pradervand, S. & Reymond, A. (2011) Copy number variation modifies expression time courses. Genome Res., 21, 106-113.
13. Citri, A. & Malenka, R.C. (2008) Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology, 33, 18-41.
14. Collins, M.O., Husi, H., Yu, L., Brandon, J.M., Anderson, C.N., Blackstock, W.P., Choudhary, J.S. & Grant, S.G. (2006) Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J. Neurochem., 97(Suppl. 1), 16-23.
15. Creese, I., Burt, D.R. & Snyder, S.H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192, 481-483.
16. Crowley, J.J., Hilliard, C.E., Kim, Y., Morgan, M.B., Lewis, L.R., Muzny, D.M., Hawes, A.C., Sabo, A., Wheeler, D.A., Lieberman, J.A., Sullivan, P.F. & Gibbs, R.A. (2013) Deep resequencing and association analysis of schizophrenia candidate genes. Mol. Psychiatr., 18, 138-140.
17. Damask, S.P., Bovenkerk, K.A., de la Pena, G., Hoversten, K.M., Peters, D.B., Valentine, A.M. & Meador-Woodruff, J.H. (1996) Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex. Brain Res. Mol. Brain Res., 41, 241-249.
18. Dudbridge, F. & Gusnanto, A. (2008) Estimation of significance thresholds for genomewide association scans. Genet. Epidemiol., 32, 227-234.
19. von Eichborn, J., Dunkel, M., Gohlke, B.O., Preissner, S.C., Hoffmann, M.F., Bauer, J.M., Armstrong, J.D., Schaefer, M.H., Andrade-Navarro, M.A., Le Novere, N., Croning, M.D., Grant, S.G., van Nierop, P., Smit, A.B. & Preissner, R. (2013) SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations. Nucleic Acids Res., 41, D834-D840.
20. Farr, C.D., Gafken, P.R., Norbeck, A.D., Doneanu, C.E., Stapels, M.D., Barofsky, D.F., Minami, M. & Saugstad, J.A. (2004) Proteomic analysis of native metabotropic glutamate receptor 5 protein complexes reveals novel molecular constituents. J. Neurochem., 91, 438-450.
21. Fernandez, E., Collins, M.O., Uren, R.T., Kopanitsa, M.V., Komiyama, N.H., Croning, M.D., Zografos, L., Armstrong, J.D., Choudhary, J.S. & Grant, S.G. (2009) Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol. Syst. Biol., 5, 269.
22. Freedman, R., Olincy, A., Ross, R.G., Waldo, M.C., Stevens, K.E., Adler, L.E. & Leonard, S. (2003) The genetics of sensory gating deficits in schizophrenia. Curr. Psychiatry Rep., 5, 155-161.
23. Girard, S.L., Gauthier, J., Noreau, A., Xiong, L., Zhou, S., Jouan, L., Dionne-Laporte, A., Spiegelman, D., Henrion, E., Diallo, O., Thibodeau, P., Bachand, I., Bao, J.Y., Tong, A.H., Lin, C.H., Millet, B., Jaafari, N., Joober, R., Dion, P.A., Lok, S., Krebs, M.O. & Rouleau, G.A. (2011) Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet., 43, 860-863.
24. Girirajan, S., Rosenfeld, J.A., Coe, B.P., Parikh, S., Friedman, N., Goldstein, A., Filipink, R.A., McConnell, J.S., Angle, B., Meschino, W.S., Nezarati, M.M., Asamoah, A., Jackson, K.E., Gowans, G.C., Martin, J.A., Carmany, E.P., Stockton, D.W., Schnur, R.E., Penney, L.S., Martin, D.M., Raskin, S., Leppig, K., Thiese, H., Smith, R., Aberg, E., Niyazov, D.M., Escobar, L.F., El-Khechen, D., Johnson, K.D., Lebel, R.R., Siefkas, K., Ball, S., Shur, N., McGuire, M., Brasington, C.K., Spence, J.E., Martin, L.S., Clericuzio, C., Ballif, B.C., Shaffer, L.G. & Eichler, E.E. (2012) Phenotypic heterogeneity of genomic disorders and rare copy-number variants. New Engl. J. Med., 367, 1321-1331.
25. Glessner, J.T., Reilly, M.P., Kim, C.E., Takahashi, N., Albano, A., Hou, C., Bradfield, J.P., Zhang, H., Sleiman, P.M., Flory, J.H., Imielinski, M., Frackelton, E.C., Chiavacci, R., Thomas, K.A., Garris, M., Otieno, F.G., Davidson, M., Weiser, M., Reichenberg, A., Davis, K.L., Friedman, J.I., Cappola, T.P., Margulies, K.B., Rader, D.J., Grant, S.F., Buxbaum, J.D., Gur, R.E. & Hakonarson, H. (2010) Strong synaptic transmission impact by copy number variations in schizophrenia. Proc. Natl. Acad. Sci. USA, 107, 10584-10589.
26. Gronborg, M., Pavlos, N.J., Brunk, I., Chua, J.J., Munster-Wandowski, A., Riedel, D., Ahnert-Hilger, G., Urlaub, H. & Jahn, R. (2010) Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J. Neurosci., 30, 2-12.
27. Gulsuner, S., Walsh, T., Watts, A.C., Lee, M.K., Thornton, A.M., Casadei, S., Rippey, C., Shahin, H., Nimgaonkar, V.L., Go, R.C., Savage, R.M., Swerdlow, N.R., Gur, R.E., Braff, D.L., King, M.C. & McClellan, J.M. (2013) Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell, 154, 518-529.
28. Harrison, P.J., Lyon, L., Sartorius, L.J., Burnet, P.W. & Lane, T.A. (2008) The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia. J. Psychopharmacol., 22, 308-322.
29. Healy, D.J. & Meador-Woodruff, J.H. (1997) Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum. Brain Res. Mol. Brain Res., 47, 331-338.
30. Heller, E.A., Zhang, W., Selimi, F., Earnheart, J.C., Slimak, M.A., Santos-Torres, J., Ibanez-Tallon, I., Aoki, C., Chait, B.T. & Heintz, N. (2012) The biochemical anatomy of cortical inhibitory synapses. PLoS One, 7, e39572.
31. Henrichsen, C.N., Vinckenbosch, N., Zollner, S., Chaignat, E., Pradervand, S., Schutz, F., Ruedi, M., Kaessmann, H. & Reymond, A. (2009) Segmental copy number variation shapes tissue transcriptomes. Nat. Genet., 41, 424-429.
32. Husi, H. & Grant, S.G. (2001) Isolation of 2000-kDa complexes of N-methyl-d-aspartate receptor and postsynaptic density 95 from mouse brain. J. Neurochem., 77, 281-291.
33. Husi, H., Ward, M.A., Choudhary, J.S., Blackstock, W.P. & Grant, S.G. (2000) Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci., 3, 661-669.
34. International HapMap Consortium (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
35. International Schizophrenia Consortium (2008) Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature, 455, 237-241.
36. International Schizophrenia Consortium, Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O'Donovan, M.C., Sullivan, P.F. & Sklar, P. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460, 748-752.
37. Javitt, D.C. & Zukin, S.R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat., 148, 1301-1308.
38. Jordan, B.A., Fernholz, B.D., Boussac, M., Xu, C., Grigorean, G., Ziff, E.B. & Neubert, T.A. (2004) Identification and verification of novel rodent postsynaptic density proteins. Mol. Cell. Proteomics, 3, 857-871.
39. Kim, J.S., Kornhuber, H.H., Schmid-Burgk, W. & Holzmuller, B. (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett., 20, 379-382.
40. Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., O'Donovan, M.C., Erdogan, F., Owen, M.J., Ropers, H.H. & Ullmann, R. (2008) Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet., 17, 458-465.
41. Kirov, G., Pocklington, A.J., Holmans, P., Ivanov, D., Ikeda, M., Ruderfer, D., Moran, J., Chambert, K., Toncheva, D., Georgieva, L., Grozeva, D., Fjodorova, M., Wollerton, R., Rees, E., Nikolov, I., van de Lagemaat, L.N., Bayes, A., Fernandez, E., Olason, P.I., Bottcher, Y., Komiyama, N.H., Collins, M.O., Choudhary, J., Stefansson, K., Stefansson, H., Grant, S.G., Purcell, S., Sklar, P., O'Donovan, M.C. & Owen, M.J. (2012) De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatr., 17, 142-153.
42. Laursen, T.M. & Munk-Olsen, T. (2010) Reproductive patterns in psychotic patients. Schizophr. Res., 121, 234-240.
43. Lee, S.H., DeCandia, T.R., Ripke, S. & Yang, J., The Schizophrenia Psychiatric Genome Wide Association Study Consortium (PGC-SCZ), The International Schizophrenia Consortium (ISC), The Molecular Genetics of Schizophrenia Collaboration (MGS), Sullivan, P.F., Goddard, M.E., Keller, M.C., Visscher, P.M. & Wray, N.R. (2012) Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet., 44, 247-250.
44. de Leon, J. & Diaz, F.J. (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res., 76, 135-157.
45. de Leon, J., Armstrong, S.C. & Cozza, K.L. (2005) The dosing of atypical antipsychotics. Psychosomatics, 46, 262-273.
46. Levinson, D.F., Duan, J., Oh, S., Wang, K., Sanders, A.R., Shi, J., Zhang, N., Mowry, B.J., Olincy, A., Amin, F., Cloninger, C.R., Silverman, J.M., Buccola, N.G., Byerley, W.F., Black, D.W., Kendler, K.S., Freedman, R., Dudbridge, F., Pe'er, I., Hakonarson, H., Bergen, S.E., Fanous, A.H., Holmans, P.A. & Gejman, P.V. (2011) Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiat., 168, 302-316.
47. Lewis, D.A., Hashimoto, T. & Volk, D.W. (2005) Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci., 6, 312-324.
48. Li, K.W., Hornshaw, M.P., Van Der Schors, R.C., Watson, R., Tate, S., Casetta, B., Jimenez, C.R., Gouwenberg, Y., Gundelfinger, E.D., Smalla, K.H. & Smit, A.B. (2004a) Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J. Biol. Chem., 279, 987-1002.
49. Li, M.D., Kane, J.K., Wang, J. & Ma, J.Z. (2004b) Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Brain Res. Mol. Brain Res., 132, 168-180.
50. Lodge, D. & Anis, N.A. (1982) Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. Eur. J. Pharmacol., 77, 203-204.
51. Luo, R., Sanders, S.J., Tian, Y., Voineagu, I., Huang, N., Chu, S.H., Klei, L., Cai, C., Ou, J., Lowe, J.K., Hurles, M.E., Devlin, B., State, M.W. & Geschwind, D.H. (2012) Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am. J. Hum. Genet., 91, 38-55.
52. Malenka, R.C. & Nicoll, R.A. (1993) NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci., 16, 521-527.
53. Malhotra, D. & Sebat, J. (2012) CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell, 148, 1223-1241.
54. Mauri, M.C., Volonteri, L.S., Colasanti, A., Fiorentini, A., De Gaspari, I.F. & Bareggi, S.R. (2007) Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin. Pharmacokinet., 46, 359-388.
55. Meyer, U., Feldon, J. & Fatemi, S.H. (2009) In vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci. Biobehav. R., 33, 1061-1079.
56. Mistry, M. & Pavlidis, P. (2010) A cross-laboratory comparison of expression profiling data from normal human postmortem brain. Neuroscience, 167, 384-395.
57. Mistry, M., Gillis, J. & Pavlidis, P. (2013) Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol. Psychiatr., 18, 215-225.
58. Morciano, M., Burre, J., Corvey, C., Karas, M., Zimmermann, H. & Volknandt, W. (2005) Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis. J. Neurochem., 95, 1732-1745.
59. Morciano, M., Beckhaus, T., Karas, M., Zimmermann, H. & Volknandt, W. (2009) The proteome of the presynaptic active zone: from docked synaptic vesicles to adhesion molecules and maxi-channels. J. Neurochem., 108, 662-675.
60. Muller, C.S., Haupt, A., Bildl, W., Schindler, J., Knaus, H.G., Meissner, M., Rammner, B., Striessnig, J., Flockerzi, V., Fakler, B. & Schulte, U. (2010) Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proc. Natl. Acad. Sci. USA, 107, 14950-14957.
61. Need, A.C., McEvoy, J.P., Gennarelli, M., Heinzen, E.L., Ge, D., Maia, J.M., Shianna, K.V., He, M., Cirulli, E.T., Gumbs, C.E., Zhao, Q., Campbell, C.R., Hong, L., Rosenquist, P., Putkonen, A., Hallikainen, T., Repo-Tiihonen, E., Tiihonen, J., Levy, D.L., Meltzer, H.Y. & Goldstein, D.B. (2012) Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am. J. Hum. Genet., 91, 303-312.
62. Nestler, E.J. & Hyman, S.E. (2010) Animal models of neuropsychiatric disorders. Nat. Neurosci., 13, 1161-1169.
63. Nithianantharajah, J. & Grant, S.G. (2013) Cognitive components in mice and humans: Combining genetics and touchscreens for medical translation. Neurobiol. Learn. Mem., 105, 13-19.
64. O'Connor, J.A., Muly, E.C., Arnold, S.E. & Hemby, S.E. (2007) AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophr. Res., 90, 28-40.
65. Olney, J.W. & Farber, N.B. (1995) Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiat., 52, 998-1007.
66. Paulo, J.A., Brucker, W.J. & Hawrot, E. (2009) Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome. J. Proteome Res., 8, 1849-1858.
67. Peng, J., Kim, M.J., Cheng, D., Duong, D.M., Gygi, S.P. & Sheng, M. (2004) Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J. Biol. Chem., 279, 21003-21011.
68. Perez-Santiago, J., Diez-Alarcia, R., Callado, L.F., Zhang, J.X., Chana, G., White, C.H., Glatt, S.J., Tsuang, M.T., Everall, I.P., Meana, J.J. & Woelk, C.H. (2012) A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J. Psychiatr. Res., 46, 1464-1474.
69. Pocklington, A.J., Cumiskey, M., Armstrong, J.D. & Grant, S.G. (2006) The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol. Syst. Biol., 2, 2006.0023.
70. Raedler, T.J., Bymaster, F.P., Tandon, R., Copolov, D. & Dean, B. (2007) Towards a muscarinic hypothesis of schizophrenia. Mol. Psychiatr., 12, 232-246.
71. Raychaudhuri, S., Korn, J.M., McCarroll, S.A., Altshuler, D., Sklar, P., Purcell, S. & Daly, M.J. (2010) Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genet., 6, e1001097.
72. Rees, E., Walters, J.T., Georgieva, L., Isles, A.R., Chambert, K.D., Richards, A.L., Mahoney-Davies, G., Legge, S.E., Moran, J.L., McCarroll, S.A., O'Donovan, M.C., Owen, M.J. & Kirov, G. (2014) Analysis of copy number variations at 15 schizophrenia-associated loci. Brit. J. Psychiat., 204, 108-114.
73. Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J.L., Kahler, A.K., Akterin, S., Bergen, S.E., Collins, A.L., Crowley, J.J., Fromer, M., Kim, Y., Lee, S.H., Magnusson, P.K., Sanchez, N., Stahl, E.A., Williams, S., Wray, N.R., Xia, K., Bettella, F., Borglum, A.D., Bulik-Sullivan, B.K., Cormican, P., Craddock, N., de Leeuw, C., Durmishi, N., Gill, M., Golimbet, V., Hamshere, M.L., Holmans, P., Hougaard, D.M., Kendler, K.S., Lin, K., Morris, D.W., Mors, O., Mortensen, P.B., Neale, B.M., O'Neill, F.A., Owen, M.J., Milovancevic, M.P., Posthuma, D., Powell, J., Richards, A.L., Riley, B.P., Ruderfer, D., Rujescu, D., Sigurdsson, E., Silagadze, T., Smit, A.B., Stefansson, H., Steinberg, S., Suvisaari, J., Tosato, S., Verhage, M., Walters, J.T., Levinson, D.F., Gejman, P.V., Kendler, K.S., Laurent, C., Mowry, B.J., O'Donovan, M.C., Owen, M.J., Pulver, A.E., Riley, B.P., Schwab, S.G., Wildenauer, D.B., Dudbridge, F., Holmans, P., Shi, J., Albus, M., Alexander, M., Campion, D., Cohen, D., Dikeos, D., Duan, J., Eichhammer, P., Godard, S., Hansen, M., Lerer, F.B., Liang, K.Y., Maier, W., Mallet, J., Nertney, D.A., Nestadt, G., Norton, N., O'Neill, F.A., Papadimitriou, G.N., Ribble, R., Sanders, A.R., Silverman, J.M., Walsh, D., Williams, N.M., Wormley, B., Arranz, M.J., Bakker, S., Bender, S., Bramon, E., Collier, D., Crespo-Facorro, B., Hall, J., Iyegbe, C., Jablensky, A., Kahn, R.S., Kalaydjieva, L., Lawrie, S., Lewis, C.M., Lin, K., Linszen, D.H., Mata, I., McIntosh, A., Murray, R.M., Ophoff, R.A., Powell, J., Rujescu, D., Van Os, J., Walshe, M., Weisbrod, M., Wiersma, D., Donnelly, P., Barroso, I., Blackwell, J.M., Bramon, E., Brown, M.A., Casas, J.P., Corvin, A.P., Deloukas, P., Duncanson, A., Jankowski, J., Markus, H.S., Mathew, C.G., Palmer, C.N., Plomin, R., Rautanen, A., Sawcer, S.J., Trembath, R.C., Viswanathan, A.C., Wood, N.W., Spencer, C.C., Band, G., Bellenguez, C., Freeman, C., Hellenthal, G., Giannoulatou, E., Pirinen, M., Pearson, R.D., Strange, A., Su, Z., Vukcevic, D., Donnelly, P., Langford, C., Hunt, S.E., Edkins, S., Gwilliam, R., Blackburn, H., Bumpstead, S.J., Dronov, S., Gillman, M., Gray, E., Hammond, N., Jayakumar, A., McCann, O.T., Liddle, J., Potter, S.C., Ravindrarajah, R., Ricketts, M., Tashakkori-Ghanbaria, A., Waller, M.J., Weston, P., Widaa, S., Whittaker, P., Barroso, I., Deloukas, P., Mathew, C.G., Blackwell, J.M., Brown, M.A., Corvin, A.P., McCarthy, M.I., Spencer, C.C., Bramon, E., Corvin, A.P., O'Donovan, M.C., Stefansson, K., Scolnick, E., Purcell, S., McCarroll, S.A., Sklar, P., Hultman, C.M. & Sullivan, P.F. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet., 45, 1150-1159.
74. Saha, S., Chant, D., Welham, J. & McGrath, J. (2005) A systematic review of the prevalence of schizophrenia. PLoS Med., 2, e141.
75. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) Genome-wide association study identifies five new schizophrenia loci. Nat. Genet., 43, 969-976.
76. Schmitt, A., Zink, M., Petroianu, G., May, B., Braus, D.F. & Henn, F.A. (2003) Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain. Neurosci. Lett., 347, 81-84.
77. Scott, J.D. & Pawson, T. (2009) Cell signaling in space and time: where proteins come together and when they're apart. Science, 326, 1220-1224.
78. Seeman, P., Lee, T., Chau-Wong, M. & Wong, K. (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261, 717-719.
79. Selimi, F., Cristea, I.M., Heller, E., Chait, B.T. & Heintz, N. (2009) Proteomic studies of a single CNS synapse type: the parallel fiber/purkinje cell synapse. PLoS Biol., 7, e83.
80. Sheng, M. & Hoogenraad, C.C. (2007) The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu. Rev. Biochem., 76, 823-847.
81. Smoller, J.W., Craddock, N., Kendler, K., Lee, P.H., Neale, B.M., Nurnberger, J.I., Ripke, S., Santangelo, S. & Sullivan, P.F. (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet, 381, 1371-1379.
82. Smrt, R.D., Szulwach, K.E., Pfeiffer, R.L., Li, X., Guo, W., Pathania, M., Teng, Z.Q., Luo, Y., Peng, J., Bordey, A., Jin, P. & Zhao, X. (2010) MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells, 28, 1060-1070.
83. Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O.P., Mors, O., Mortensen, P.B., Sigurdsson, E., Gustafsson, O., Nyegaard, M., Tuulio-Henriksson, A., Ingason, A., Hansen, T., Suvisaari, J., Lonnqvist, J., Paunio, T., Borglum, A.D., Hartmann, A., Fink-Jensen, A., Nordentoft, M., Hougaard, D., Norgaard-Pedersen, B., Bottcher, Y., Olesen, J., Breuer, R., Moller, H.J., Giegling, I., Rasmussen, H.B., Timm, S., Mattheisen, M., Bitter, I., Rethelyi, J.M., Magnusdottir, B.B., Sigmundsson, T., Olason, P., Masson, G., Gulcher, J.R., Haraldsson, M., Fossdal, R., Thorgeirsson, T.E., Thorsteinsdottir, U., Ruggeri, M., Tosato, S., Franke, B., Strengman, E., Kiemeney, L.A., Melle, I., Djurovic, S., Abramova, L., Kaleda, V., Sanjuan, J., de Frutos, R., Bramon, E., Vassos, E., Fraser, G., Ettinger, U., Picchioni, M., Walker, N., Toulopoulou, T., Need, A.C., Ge, D., Yoon, J.L., Shianna, K.V., Freimer, N.B., Cantor, R.M., Murray, R., Kong, A., Golimbet, V., Carracedo, A., Arango, C., Costas, J., Jonsson, E.G., Terenius, L., Agartz, I., Petursson, H., Nothen, M.M., Rietschel, M., Matthews, P.M., Muglia, P., Peltonen, L., St Clair, D., Goldstein, D.B., Stefansson, K. & Collier, D.A. (2009) Common variants conferring risk of schizophrenia. Nature, 460, 744-747.
84. Stranger, B.E., Forrest, M.S., Dunning, M., Ingle, C.E., Beazley, C., Thorne, N., Redon, R., Bird, C.P., de Grassi, A., Lee, C., Tyler-Smith, C., Carter, N., Scherer, S.W., Tavare, S., Deloukas, P., Hurles, M.E. & Dermitzakis, E.T. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science, 315, 848-853.
85. Stroup, T.S. (2007) Heterogeneity of treatment effects in schizophrenia. Am. J. Med., 120, S26-S31.
86. Sudhof, T.C. (2004) The synaptic vesicle cycle. Annu. Rev. Neurosci., 27, 509-547.
87. Sullivan, P.F. (2013) Questions about DISC1 as a genetic risk factor for schizophrenia. Mol. Psychiatr., 18, 1050-1052.
88. Sullivan, P.F., Kendler, K.S. & Neale, M.C. (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiat., 60, 1187-1192.
89. Takamori, S., Holt, M., Stenius, K., Lemke, E.A., Gronborg, M., Riedel, D., Urlaub, H., Schenck, S., Brugger, B., Ringler, P., Muller, S.A., Rammner, B., Grater, F., Hub, J.S., De Groot, B.L., Mieskes, G., Moriyama, Y., Klingauf, J., Grubmuller, H., Heuser, J., Wieland, F. & Jahn, R. (2006) Molecular anatomy of a trafficking organelle. Cell, 127, 831-846.
90. Takata, A., Iwayama, Y., Fukuo, Y., Ikeda, M., Okochi, T., Maekawa, M., Toyota, T., Yamada, K., Hattori, E., Ohnishi, T., Toyoshima, M., Ujike, H., Inada, T., Kunugi, H., Ozaki, N., Nanko, S., Nakamura, K., Mori, N., Kanba, S., Iwata, N., Kato, T. & Yoshikawa, T. (2013) A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol. Psychiat., 73, 532-539.
91. Tandon, R., Nasrallah, H.A. & Keshavan, M.S. (2009) Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res., 110, 1-23.
92. Thurman, R.E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M.T., Haugen, E., Sheffield, N.C., Stergachis, A.B., Wang, H., Vernot, B., Garg, K., John, S., Sandstrom, R., Bates, D., Boatman, L., Canfield, T.K., Diegel, M., Dunn, D., Ebersol, A.K., Frum, T., Giste, E., Johnson, A.K., Johnson, E.M., Kutyavin, T., Lajoie, B., Lee, B.K., Lee, K., London, D., Lotakis, D., Neph, S., Neri, F., Nguyen, E.D., Qu, H., Reynolds, A.P., Roach, V., Safi, A., Sanchez, M.E., Sanyal, A., Shafer, A., Simon, J.M., Song, L., Vong, S., Weaver, M., Yan, Y., Zhang, Z., Zhang, Z., Lenhard, B., Tewari, M., Dorschner, M.O., Hansen, R.S., Navas, P.A., Stamatoyannopoulos, G., Iyer, V.R., Lieb, J.D., Sunyaev, S.R., Akey, J.M., Sabo, P.J., Kaul, R., Furey, T.S., Dekker, J., Crawford, G.E. & Stamatoyannopoulos, J.A. (2012) The accessible chromatin landscape of the human genome. Nature, 489, 75-82.
93. Timms, A.E., Dorschner, M.O., Wechsler, J., Choi, K.Y., Kirkwood, R., Girirajan, S., Baker, C., Eichler, E.E., Korvatska, O., Roche, K.W., Horwitz, M.S. & Tsuang, D.W. (2013) Support for the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry, 70, 582-590.
94. Walikonis, R.S., Jensen, O.N., Mann, M., Provance, D.W. Jr., Mercer, J.A. & Kennedy, M.B. (2000) Identification of proteins in the postsynaptic density fraction by mass spectrometry. J. Neurosci., 20, 4069-4080.
95. Walsh, T., McClellan, J.M., McCarthy, S.E., Addington, A.M., Pierce, S.B., Cooper, G.M., Nord, A.S., Kusenda, M., Malhotra, D., Bhandari, A., Stray, S.M., Rippey, C.F., Roccanova, P., Makarov, V., Lakshmi, B., Findling, R.L., Sikich, L., Stromberg, T., Merriman, B., Gogtay, N., Butler, P., Eckstrand, K., Noory, L., Gochman, P., Long, R., Chen, Z., Davis, S., Baker, C., Eichler, E.E., Meltzer, P.S., Nelson, S.F., Singleton, A.B., Lee, M.K., Rapoport, J.L., King, M.C. & Sebat, J. (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 320, 539-543.
96. Wang, J., Gutala, R., Hwang, Y.Y., Kim, J.M., Konu, O., Ma, J.Z. & Li, M.D. (2008) Strain- and region-specific gene expression profiles in mouse brain in response to chronic nicotine treatment. Genes Brain Behav., 7, 78-87.
97. Wang, L., Jia, P., Wolfinger, R.D., Chen, X. & Zhao, Z. (2011) Gene set analysis of genome-wide association studies: methodological issues and perspectives. Genomics, 98, 1-8.
98. Xu, B., Ionita-Laza, I., Roos, J.L., Boone, B., Woodrick, S., Sun, Y., Levy, S., Gogos, J.A. & Karayiorgou, M. (2012) De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet., 44, 1365-1369.
99. Yamauchi, T. (2002) Molecular constituents and phosphorylation-dependent regulation of the post-synaptic density. Mass Spectrom. Rev., 21, 266-286.
100. Ye, T., Lipska, B.K., Tao, R., Hyde, T.M., Wang, L., Li, C., Choi, K.H., Straub, R.E., Kleinman, J.E. & Weinberger, D.R. (2012) Analysis of copy number variations in brain DNA from patients with schizophrenia and other psychiatric disorders. Biol. Psychiat., 72, 651-654.
101. Yoshimura, Y., Yamauchi, Y., Shinkawa, T., Taoka, M., Donai, H., Takahashi, N., Isobe, T. & Yamauchi, T. (2004) Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J. Neurochem., 88, 759-768.